The 2024 review of Notorious Markets for Counterfeiting and Piracy found an increase in illicit online pharmacies, many of which are selling counterfeit drugs with serious health or safety risks, according to a Jan. 8 news release from the office.
The USTR said these illegal operations are often based outside the U.S. and are difficult to regulate. The report emphasized the need for stronger enforcement against such pharmacies and also pointed to efforts by governments worldwide to crack down on counterfeiting and piracy.
With the rise of e-commerce platforms, the market for counterfeit drugs has expanded, posing significant challenges for law enforcement and the pharmaceutical industry, the report said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.